News and Trends 8 Mar 2018 French Biotech Targets Gut Microbiome to Treat Diabetes Valbiotis has shown that its treatment restores diversity in a population of gut microorganisms imbalanced by type 2 diabetes in mice. Valbiotis, based in Périgny, France, wants to treat type 2 diabetes by restoring the balance of microbial populations in the gut microbiome. New data from a metagenomic sequencing study in mice has shown that its drug, […] March 8, 2018 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
More News! 24 Feb 2018 The First and Only Museum of Microbes Captivates Amsterdam Micropia, a museum of microbes located in the heart of Amsterdam, uses art to address the big knowledge gap between science and the general public. Microbiology originated just a few kilometers from Amsterdam when Antoni van Leeuwenhoek built one of the first microscopes and discovered that everyday objects, as well as himself, were teeming with minuscule forms of life. More […] February 24, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 4 Jan 2018 Enterome Brings in a €32M Series D for its Microbiome-Based Therapies Enterome will use the money to progress two of its leading microbiome programs for the treatment of Crohn’s disease and an aggressive form of brain cancer. Enterome is a pioneer in the exciting field of microbiome-based therapies for diseases like inflammatory bowel diseases and cancer. This morning, the company has announced that it has raised €32M in […] January 4, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 20 Dec 2017 Israeli Biotech Acquires Microbiome Company to Fight Chronic Liver Disease BiomX has acquired RondinX, expanding its bacterial target discovery platform and adding new microbiome targets for chronic liver disease. BiomX is a company based in Ness Ziona, Israel, developing customized phage therapy to selectively destroy the bacteria that cause diseases ranging from inflammatory bowel disease (IBD) to cancer. The company has just acquired RondinX, another […] December 20, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 30 Nov 2017 Qiagen Joins French Biotech to Build the Next Generation of Microbiome Technology Biomillenia harnesses the power of bacteria to keep the body healthy. The biotech has joined forces with Qiagen to develop microbiome-on-a-chip technology. Scientists around the world believe that the microbiome could hold the key to human health. One company in this area, Biomillenia, develops microbial strains from previously unculturable microbiomes to unlock its full potential. The company has now […] November 30, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 28 Sep 2017 French Microbiome Biotech Gets a €6.5M Leg Up to Market Launch LNC Therapeutics is ready to take its oral microbiome-based therapeutic to market for obesity. Investors have contributed a bit of cash to get it there. Bordeaux-based LNC Therapeutics has raked in €6.5M in a Series C. It has raised a total of €16.5M since it was founded in 2010. Seventure Partners, a leading VC focused […] September 28, 2017 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 26 Sep 2017 French Biotech Gets $20M to Treat the Microbiome with CRISPR Nanobots Eligo Bioscience has announced its first fundraising round, amassing $20M (€18.5M) that will be put towards bringing it CRISPR nanobots to a first clinical trial in humans. The French startup Eligo Bioscience has grown rapidly since its foundation in 2014. The company has announced today its Series A round, which, led by Khosla Ventures and […] September 26, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 22 Sep 2017 EU gives French Biotech €20M to Continue the Fight Against Antibiotic Resistance Da Volterra has been boosted by a €20M loan to speed up the development of solutions for the antibiotic resistance crisis. The French biopharma concentrates on the prevention and treatment of serious infections. This is a big area of interest due to rapidly rising antibiotic resistance. The company has been boosted by a €20M loan from the […] September 22, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 15 Sep 2017 Bayer Launches Plant Microbiome Biotech with a Huge €84M Series A Bayer and Ginkgo Bioworks are launching a new company that will develop new technologies for sustainable agriculture by engineering the plant microbiome. With the microbiome already gaining traction in the therapeutics field, Bayer has decided to take it to agriculture. In partnership with US synthetic biology upstart Ginkgo Bioworks, the German giant is creating a new […] September 15, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 9 Sep 2017 The Music of the Microbiome Questions our Identity as Humans Slovenian artists Saša Spačal, Mirjan Švagelj and Anil Podgornik explore the meaning of human identity by letting their microbiome play music. Have you ever wondered what the microbes that live in and on you would tell you if you listened to them? A group of Slovenian artists decided to let their own microbes make music, building […] September 9, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jul 2017 Enterome and Nestle Launch a New Microbiome Diagnostics Company Microbiome Diagnostics Partners will develop diagnostics tests with Enterome’s microbiome platform IP and a €20M investment from Nestlé. Nestlé Health Science and Enterome have created Microbiome Diagnostics Partners (MDP) as a joint venture split 50% between both parties. Nestlé has invested €20M for its stake in the new company as well as the exclusive option to commercialize […] July 11, 2017 - 1 minutemin - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 7 Jul 2017 Better than CRISPR? New Genetic Analysis Method ropes in Long-Read DNA Cloning After CRISPR, there’s a new genetic technique with a tongue-in-cheek name in town: LASSO cloning. Researchers from four institutions, including the US-based John Hopkins, Rutgers and Harvard, and the University of Trento in Italy, have developed a new technology to study large chunks of DNA and their function. The work behind it was recently published in Nature Biomedical […] July 7, 2017 - 3 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email